Wedmont Private Capital Novartis Ag Transaction History
Wedmont Private Capital
- $2.73 Billion
- Q4 2025
A detailed history of Wedmont Private Capital transactions in Novartis Ag stock. As of the latest transaction made, Wedmont Private Capital holds 7,416 shares of NVS stock, worth $975,574. This represents 0.04% of its overall portfolio holdings.
Number of Shares
7,416
Previous 6,467
14.67%
Holding current value
$975,574
Previous $829,000
17.61%
% of portfolio
0.04%
Previous 0.03%
Shares
11 transactions
Others Institutions Holding NVS
# of Institutions
1,614Shares Held
137MCall Options Held
1.53MPut Options Held
2.22M-
Dodge & Cox San Francisco, CA10.6MShares$1.39 Billion0.78% of portfolio
-
Primecap Management CO Pasadena, CA9.34MShares$1.23 Billion0.95% of portfolio
-
Dimensional Fund Advisors LP Austin, TX8.84MShares$1.16 Billion0.25% of portfolio
-
Morgan Stanley New York, NY7.73MShares$1.02 Billion0.06% of portfolio
-
Ken Fisher Fisher Asset Management, LLC | Camas, Wa7.24MShares$952 Million0.34% of portfolio
About NOVARTIS AG
- Ticker NVS
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,151,000,064
- Market Cap $283B
- Description
- Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...